CW ClaimWatch Consumer alert tracker

Recall

Zydus Pharmaceuticals (USA) Inc: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Recall

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit Product details: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles ...

Active Official source

Verification

Official-source record

This page is included in the public index because it is tied to a listed official source. ClaimWatch does not publish trend-only candidates to public SEO pages.

Agency
FDA
Record ID
D-0544-2026
Canonical
https://claimwatch-mvp.vercel.app/item/zydus-pharmaceuticals-usa-inc-erythromycin-tablets-usp-250-mg-30-tablets-per-bottle-rx-onl/

What happened?

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit Product details: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles ...

Who may be affected?

Nationwide within the U.S

What should consumers do?

Affected quantity: 23,880 bottles

Official source

Matched search terms

No search trend terms attached yet.

FAQ

Is this page official?

No. ClaimWatch links to official sources and marks whether a page is verified or still being monitored.

Is this legal, medical, or financial advice?

No. This page is informational. Always confirm eligibility, deadlines, and safety instructions through official sources.

Similar alerts